WallStSmart

Intuitive Surgical Inc (ISRG)vsLeMaitre Vascular Inc (LMAT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Intuitive Surgical Inc generates 4206% more annual revenue ($11.03B vs $256.28M). ISRG leads profitability with a 28.4% profit margin vs 24.3%. ISRG appears more attractively valued with a PEG of 1.78. ISRG earns a higher WallStSmart Score of 66/100 (B-).

ISRG

Strong Buy

66

out of 100

Grade: B-

Growth: 8.0Profit: 9.0Value: 6.0Quality: 7.8
Piotroski: 4/9Altman Z: 5.95

LMAT

Buy

63

out of 100

Grade: C+

Growth: 8.0Profit: 8.0Value: 2.7Quality: 8.5
Piotroski: 4/9Altman Z: 3.16
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ISRGUndervalued (+81.6%)

Margin of Safety

+81.6%

Fair Value

$1922.89

Current Price

$353.10

$1569.79 discount

UndervaluedFair: $1922.89Overvalued
LMATSignificantly Overvalued (-59.7%)

Margin of Safety

-59.7%

Fair Value

$54.96

Current Price

$102.19

$47.23 premium

UndervaluedFair: $54.96Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ISRG6 strengths · Avg: 9.0/10
Operating MarginProfitability
33.8%10/10

Strong operational efficiency at 33.8%

Altman Z-ScoreHealth
5.9510/10

Safe zone — low bankruptcy risk

Market CapQuality
$122.06B9/10

Large-cap with strong market position

Profit MarginProfitability
28.4%9/10

Keeps 28 of every $100 in revenue as profit

Revenue GrowthGrowth
18.5%8/10

18.5% revenue growth

EPS GrowthGrowth
26.5%8/10

Earnings expanding 26.5% YoY

LMAT4 strengths · Avg: 8.8/10
Altman Z-ScoreHealth
3.1610/10

Safe zone — low bankruptcy risk

Profit MarginProfitability
24.3%9/10

Keeps 24 of every $100 in revenue as profit

Operating MarginProfitability
26.7%8/10

Strong operational efficiency at 26.7%

EPS GrowthGrowth
41.7%8/10

Earnings expanding 41.7% YoY

Areas to Watch

ISRG2 concerns · Avg: 3.0/10
PEG RatioValuation
1.784/10

Expensive relative to growth rate

P/E RatioValuation
40.2x2/10

Premium valuation, high expectations priced in

LMAT2 concerns · Avg: 3.0/10
P/E RatioValuation
37.4x4/10

Premium valuation, high expectations priced in

PEG RatioValuation
2.822/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : ISRG

The strongest argument for ISRG centers on Operating Margin, Altman Z-Score, Market Cap. Profitability is solid with margins at 28.4% and operating margin at 33.8%. Revenue growth of 18.5% demonstrates continued momentum.

Bull Case : LMAT

The strongest argument for LMAT centers on Altman Z-Score, Profit Margin, Operating Margin. Profitability is solid with margins at 24.3% and operating margin at 26.7%. Revenue growth of 11.2% demonstrates continued momentum.

Bear Case : ISRG

The primary concerns for ISRG are PEG Ratio, P/E Ratio. A P/E of 40.2x leaves little room for execution misses.

Bear Case : LMAT

The primary concerns for LMAT are P/E Ratio, PEG Ratio.

Key Dynamics to Monitor

ISRG profiles as a growth stock while LMAT is a mature play — different risk/reward profiles.

ISRG carries more volatility with a beta of 1.46 — expect wider price swings.

ISRG is growing revenue faster at 18.5% — sustainability is the question.

ISRG generates stronger free cash flow (948M), providing more financial flexibility.

Bottom Line

ISRG scores higher overall (66/100 vs 63/100), backed by strong 28.4% margins and 18.5% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Intuitive Surgical Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Intuitive Surgical, Inc. is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System.

LeMaitre Vascular Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

LeMaitre Vascular, Inc. designs, markets, sells, services and supports medical devices and implants for the treatment of peripheral vascular diseases worldwide. The company is headquartered in Burlington, Massachusetts.

Want to dig deeper into these stocks?